Stockhub

Kolon Life Science Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 September 2022

  • curprev 05:3905:39, 22 September 2022‎ 95.149.241.133 talk‎ 1,150 bytes +1,150‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Kolon Life Science Inc. provides biopharmaceuticals, active pharmaceutical ingredients, pyrithione antimicrobials, and water solutions primarily in South Korea. Its biopharmaceutical product under development comprise KLS-1020, a cancer vaccine; KLS-3021, a oncolytic viral therapy; and KLS-2031 for treatment for neuropathic pain. The company also provides active pharmaceutical ingredients for anti-cancer and intermediates;..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/Kolon_Life_Science_Inc.’